Clinical Trial Update: Tygacil Drug Use Investigation

View source ↗

Summary

Pfizer reports a completed trial investigating tigecycline (Tygacil) for intra-abdominal infections and skin infections, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intra-abdominal Infection
• Skin and Soft Tissue Infection

Drugs mentioned

• TYGACIL (tigecycline)

Snippet

Sponsor: Pfizer | Conditions: Intra-Abdominal Infections, Skin Disease, Infectious | Status: COMPLETED | Results posted: 2018-12-24